Recent Advances in Managing Bullous Pemphigoid in Elderly Patients

Bullous pemphigoid (BP) is an autoimmune blistering disorder predominantly affecting the elderly, characterized by tense blisters and pruritus. The management of BP has evolved significantly, with advances in therapeutic approaches aimed at improving patient outcomes while minimizing side effects, especially in older adults. This article outlines the current updates in the management of bullous pemphigoid in elderly patients. Understanding Bullous Pemphigoid Bullous pemphigoid occurs due to the formation of autoantibodies against hemidesmosomal proteins, leading to subepidermal blistering. The disorder mostly affects individuals over 60 years of age, and its incidence is rising as the population ages. Symptoms typically include itchy urticarial plaques and tense blisters on the skin, most commonly localized to the trunk and extremities. Current Treatment Strategies The management of BP must consider the unique challenges posed by elderly patients, including comorbidities and polypharmacy. Below are the latest updates in therapeutic strategies: Topical Corticosteroids: High-potency topical corticosteroids remain the first-line treatment for localized BP, as they can effectively reduce inflammation with minimal systemic effects. Systemic Corticosteroids: For patients with extensive disease, systemic corticosteroids are often necessary. Recent guidelines recommend starting at a low dose (e.g., 0.5 mg/kg/day of prednisone) and tapering gradually to minimize side effects. Immunosuppressive Agents: Adjunctive therapies with immunosuppressants such as azathioprine or mycophenolate mofetil may be considered, particularly for patients who do not respond adequately to corticosteroids alone. Biologics: The use of biologic agents like rituximab is gaining traction in refractory cases of BP. Rituximab targets CD20+ B cells, effectively reducing the autoimmune response. Adjuvant Therapies: Supportive measures including wound care and treatment of superinfection are critical compo